EUVIMEDEUVIMED entdecken
Crossref

miR-92a-3p-inspired shRNA exhibits pro-chondrogenic and chondrocyte protective effects in osteoarthritis treatment through targeting SMAD6/7

Chenhuang Zheng, Kazuto Hoshi, Atsuhiko Hikita

Journal of Bone and Mineral Metabolism · 2024

DOI: 10.1007/s00774-023-01474-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2024. Verfasst von Chenhuang Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: MicroRNAs, Osteoarthritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Osteoarthritis (OA) compromises patients' quality of life and requires further study. Although miR-92a-3p was reported to possess chondroprotective effects, the underlying mechanism requires further clarification. The objectives of this study were to elucidate the mechanism by which miR-92a-3p alleviates OA and to examine the efficacy of shRNA-92a-3p, which was designed based on mature miR-92a-3p. MATERIALS AND METHODS: TargetScan and luciferase reporter assay were used to predict the target of miR-92a-3p. Adipose-derived stem cells (ADSCs) were transfected with miR-92a-3p/miR-NC mimic for the analysis of chondrogenic biomarkers and SMAD proteins. ADSCs and osteoarthritic chondrocytes were transduced with shRNA-92a-3p for the analysis of chondrogenic biomarkers and SMAD proteins. OA was surgically induced in C57BL/6JJcl mice, and ADSCs with/without shRNA-92a-3p transduction were intra-articularly injected for the assessment of cartilage damage. RESULTS: SMAD6 and SMAD7 were predicted as direct targets of miR-92a-3p by TargetScan and luciferase reporter assay. Transfection of the miR-92a-3p mimic resulted in a decrease in SMAD6 and SMAD7 levels and an increase in phospho-SMAD2/3, phospho-SMAD1/5/9, SOX9, collagen type II, and aggrecan levels in ADSCs. Furthermore, shRNA-92a-3p decreased SMAD6 and SMAD7 levels, and increased phospho-SMAD2/3, phospho-SMAD1/5/9, SOX9, collagen type II, and aggrecan levels in ADSCs and osteoarthritic chondrocytes. Additionally, ADSC-shRNA-92a-3p-EVs reduced the rate of decrease of SOX9, collagen type II, and aggrecan in osteoarthritic chondrocytes. In mice with surgically induced OA, shRNA-92a-3p-treated ADSCs alleviated cartilage damage more effectively than nontreated ADSCs. CONCLUSIONS: miR-92a-3p and shRNA-92a-3p exhibit therapeutic effects in treating OA by targeting SMAD6 and SMAD7, thereby enhancing TGF-β signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteoarthritisHumansAnimalsMiceChondrocytesRNA, Small InterferingCollagen Type IIAggrecansQuality of LifeMice, Inbred C57BLSmad ProteinsBiomarkersLuciferasesSmad6 Protein

Stichwörter der Autor:innen

Adipose-derived stem cellsOsteoarthritismiR-92a-3p

Substanzen

MicroRNAsRNA, Small InterferingCollagen Type IIAggrecansSmad ProteinsBiomarkersLuciferasesSMAD6 protein, humanSmad6 Protein

Autor:innen und Institutionen

  • Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
  • Department of Tissue Engineering, The University of Tokyo Hospital, Bunkyo City, 7 Chome-3-1 Hongo, Tokyo, 113-8655, Japan.
  • Department of Oral-Maxillofacial Surgery, Dentistry and Orthodontics, The University of Tokyo Hospital, Tokyo, 113-8655, Japan.
  • Department of Tissue Engineering, The University of Tokyo Hospital, Bunkyo City, 7 Chome-3-1 Hongo, Tokyo, 113-8655, Japan. ahikita-tky@g.ecc.u-tokyo.ac.jp.
  • Department of Oral-Maxillofacial Surgery, Dentistry and Orthodontics, The University of Tokyo Hospital, Tokyo, 113-8655, Japan. ahikita-tky@g.ecc.u-tokyo.ac.jp.

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Zheng, C., Hoshi, K., & Hikita, A. (2024). miR-92a-3p-inspired shRNA exhibits pro-chondrogenic and chondrocyte protective effects in osteoarthritis treatment through targeting SMAD6/7. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-023-01474-3

Vancouver

Zheng C, Hoshi K, Hikita A. miR-92a-3p-inspired shRNA exhibits pro-chondrogenic and chondrocyte protective effects in osteoarthritis treatment through targeting SMAD6/7. Journal of Bone and Mineral Metabolism. 2024. doi:10.1007/s00774-023-01474-3

BibTeX
@article{Zheng2024,
  author = {Zheng, Chenhuang and Hoshi, Kazuto and Hikita, Atsuhiko},
  title = {miR-92a-3p-inspired shRNA exhibits pro-chondrogenic and chondrocyte protective effects in osteoarthritis treatment through targeting SMAD6/7},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2024},
  doi = {10.1007/s00774-023-01474-3}
}
Kostenlos starten →